Seth Rudnick - Jun 17, 2021 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role: Director
Signature: /s/ James Stillman Hanson, attorney-in-fact
Stock symbol: GTHX
Transactions as of: Jun 17, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/21/2021, 04:06 PM
Next filing: Jun 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Award	$0	+4.39K		$0.00	4.39K	Jun 17, 2021	Direct	F1, F2
holding	GTHX	Common Stock						5.27K	Jun 17, 2021	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Options (Right to Buy)	Award	$0	+19.6K		$0.00	19.6K	Jun 17, 2021	Common Stock	19.6K	$21.97	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.
F2	Each RSU represents a contingent right to receive one share of Issuer common stock
F3	These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F4	The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.